Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
New COO at Hemab Therapeutics: Anant Murthy to Advance Rare Blood Disorder Treatments
Sep 2, 2025, 12:50

New COO at Hemab Therapeutics: Anant Murthy to Advance Rare Blood Disorder Treatments

 

Hemab Therapeutics posted on X:

”Hemab is growing fast, and we’re thrilled to announce our new Chief Operating Officer, Anant Murthy, PhD.

In this new role, Dr. Murthy will lead the company’s global efforts in market access, launch, and commercialization, bringing Hemab’s promising pipeline of treatments for Glanzmann thrombasthenia, Von Willebrand disease,  and other neglected blood clotting disorders with high unmet needs to patients worldwide.

Read more here.”

 

Stay updated with Hemostasis Today.